Anti-transferrin receptor antibodies and uses thereof
US10913800B2 · kind B2 · utility
13Cited by
56References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 9, 2020 |
| Grant date | Feb 9, 2021 |
| Priority date | — |
| Expiry date | Jun 9, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/3513
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein, in certain embodiments, are anti-transferrin receptor antibodies, anti-transferrin receptor antibody conjugates, and pharmaceutical compositions which comprise the anti-transferrin receptor antibodies or conjugates. In some embodiments, also disclosed herein are methods of delivering a payload utilizing an anti-transferrin receptor antibody described herein, and methods of treatment with use of an anti-transferrin receptor antibody described herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.